Reflect Scientific, Inc.
Income Statement
| Line Item | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $514.0K | $590.1K | $428.8K | $188.8K | $525.9K | $124.4K | $241.1K | $478.9K |
| Cost of Revenue | $186.2K | $231.5K | $187.0K | $110.4K | $195.9K | $63.9K | $113.6K | $269.8K |
| Gross Profit | $327.8K | $358.6K | $241.8K | $78.4K | $330.0K | $60.5K | $127.5K | $209.0K |
| Gross Margin | 63.8% | 60.8% | 56.4% | 41.5% | 62.8% | 48.7% | 52.9% | 43.7% |
| Operating Expenses | ||||||||
| Research & Development | $3.1K | $4.6K | $7.4K | $9.0K | $9.1K | $5.4K | $6.1K | $15.0K |
| SG&A Expense | $87.6K | $107.6K | $132.3K | $116.0K | $84.3K | $81.4K | $107.0K | $103.9K |
| Operating Income | $99.2K | $98.3K | $-40.5K | $-219.6K | $80.9K | $-180.8K | $-147.8K | $-61.3K |
| Operating Margin | 19.3% | 16.7% | -9.4% | -116.3% | 15.4% | -145.3% | -61.3% | -12.8% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | $110.0K | $98.3K | $-32.0K | $-216.4K | $86.3K | $-180.8K | $-147.8K | $-61.3K |
| Income Tax Expense | $100 | — | — | — | — | $312 | — | — |
| Net Income | $109.9K | $109.0K | $-32.0K | $-216.4K | $86.3K | $-181.1K | $-147.8K | $-61.3K |
| Net Margin | 21.4% | 18.5% | -7.5% | -114.6% | 16.4% | -145.6% | -61.3% | -12.8% |
| EPS (Basic) | $0.00 | $0.00 | $0.00 | $-0.01 | $0.00 | $0.00 | $0.00 | $0.00 |
| EPS (Diluted) | $0.00 | $0.00 | $0.00 | $-0.01 | $0.00 | $0.00 | $0.00 | $0.00 |
| Shares Outstanding (Basic) | 85.7M | 85.7M | 85.7M | 85.2M | 85.2M | 85.2M | 85.2M | 85.0M |
| Shares Outstanding (Diluted) | 85.7M | 85.7M | 85.7M | 85.2M | 85.7M | 85.2M | 85.2M | 85.4M |
| Dividends Per Share | — | — | — | — | — | — | — | — |